Iovance Biotherapeutics, Inc. (IOVA)
Market Closed
17 Jul, 20:00
$
5. 00
+0.34
+7.2961%
$
1.51B Market Cap
- P/E Ratio
- Div Yield
23.32M Volume
-1.87 Eps
$ 4.66
Previous Close 
Want to track IOVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Iovance Biotherapeutics, Inc. (IOVA) Statistics
Valuation metrics
Market Cap 1.51B
Enterprise value 1.64B
Trailing P/E (ttm) -5.43
Forward P/E -12.88
PEG ratio -0.18
Price/Sales (ttm) 6.26
Price/Book (mrq) 2.9
Enterprise Value/Revenue 5.74
Enterprise Value/EBITDA -5.1
Overview
Shares outstanding 438.11M
Float 387.98M
Shares short 114.71M
% Held by insiders 0%
% Held by institutions 0.67%
Average volume (10 days) 21.94M
Average volume (90 days) 15.69M
Price summary
52-Week low 1.76
52-Week high 5.63
Beta 0.69
50-Day moving average 4.21
200-Day moving average 3.46
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.24%
Operating margin -1.27%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.5%
Income Statement
Revenue (ttm) 285.61M
Revenue per share (ttm) 0.68
Quarterly revenue growth (yoy) 0.45%
Gross profit (ttm) 112.64M
EBITDA -321.62M
Net income to common (ttm) -353.86M
Diluted EPS (ttm) -0.85
Quarterly earnings growth (yoy) 0.45%
Balance Sheet
Total cash (mrq) 313.44M
Total cash per share (mrq) 0.75
Total debt (mrq) 47.78M
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 3.6%
Book value per share (mrq) 1.72
Cash Flow
Cash flow statement -270.79M
Levered free cash flow (LFCF) -149.07M
